Elsevier Launches Exam Consult – an Online Exam Preparation Tool for UK Medical School Exams

May 5, 2011

LONDON, May 5, 2011 /PRNewswire-FirstCall/ — Elsevier, the world-leading
publisher of scientific, technical and medical information products and
services, announces the launch of Exam Consult, an online exam preparation
and simulation tool. The first of several online question banks planned for
2011, the initial release offers preparation for the challenging medical
finals exams.

Exam Consult offers students the opportunity to prepare with questions
closely matched to their curriculum, written by expert contributors and
assessed by a panel of experts (
http://www.examconsult.co.uk/examconsult/contributors.cfm). John Rees, Head
of Medical Education and Dean of Undergraduate Education at King’s College
London School of Medicine has been heavily involved with the creation of Exam
Consult and offers the following assurance, “As an external examiner for two
UK Medical Schools, I know the types of questions asked and Exam Consult
really offers realistic finals practice, with a mix of single-best answer
questions and extended-matching questions for all disciplines.”

Further, Exam Consult allows students to identify their areas of weakness
by system, discipline, competence and in comparison to peers. This detailed
analysis of results is uniquely available with Exam Consult and allows
students to tailor their preparation, therefore maximizing efficiency.
Students can further address their weak areas with targeted learning provided
by trusted Elsevier brands, including Kumar & Clark’s Clinical Medicine,
Davidson’s Principles and Practice of Medicine and the Crash Course series.

Feedback from students demonstrates Exam Consult is well received by
students, “Easy to use and fully comprehensive – excellent preparation for
Finals exams,” 5th year medical student, Newcastle University.

A free 7-day trial of Exam Consult is available at
http://www.examconsult.co.uk. Full subscriptions are available for 3 months,
6 months or 12 months. For subscriptions or further information, please visit

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. The company works in partnership
with the global science and health communities to publish more than 2,000
journals, including The Lancet (http://www.thelancet.com/) and Cell
(http://www.cell.com/), and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier’s online solutions include
SciVerse ScienceDirect (http://www.sciencedirect.com/), SciVerse Scopus
(http://www.scopus.com/home.url), Reaxys (https://www.reaxys.com/info/), MD
Consult (http://www.mdconsult.com/php/240581084-199/homepage) and Nursing
Consult (http://www.nursingconsult.com/php/240586898-10/home.html), which
enhance the productivity of science and health professionals, and the SciVal
suite (http://www.scival.com/) and MEDai’s Pinpoint Review (
http://www.medai.com/), which help research and health care institutions
deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier
(http://www.elsevier.com/wps/find/homepage.cws_home) employs 7,000 people
worldwide. The company is part of Reed Elsevier Group PLC (
http://www.reedelsevier.com/Pages/Home.aspx), a world-leading publisher and
information provider, which is jointly owned by Reed Elsevier PLC and Reed
Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London
Stock Exchange), RUK and ENL (New York Stock Exchange).

    Media Contact
    Tom Reller
    VP, Corporate Relations, Elsevier

SOURCE Elsevier

Source: newswire

comments powered by Disqus